03 Apr 2020 administrator COVID19, Hočkinov limfom, Hronična limfocitna leukemija, Leukemije, Multipli mijelom, Nehočkinski limfom FINDINGS FROM A RETROSPECTIVE CASE STUDY OF COVID-19 INFECTION IN CANCER PATIENTS IN WUHAN: AN EMPHASIS ON SEVERE EVENTS Analysis of risk factors associated with admission to an intensive care unit, the use of mechanical ventilation or deathDate:30 Mar
06 Aug 2019 administrator Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies Overweight and obesity are a global health problem. During the last 40 years, the number of obese adults increased from 100 million in 1975 (69
02 May 2019 administrator Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL The American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and
04 Dec 2018 administrator Hočkinov limfom A small change makes a big difference in Hodgkin lymphoma At first glance, it may not seem like much, a post hoc retrospective analysis of outcomes for patients with different levels
26 Jun 2018 administrator Hočkinov limfom What are the effects of different doses and treatments for limited stage classical Hodgkin’s lymphoma? This study investigated the effects of increasing the initial dose of chemotherapy in patients with classical Hodgkin’s lymphoma (cHL). The main